The technology is based on research at University of Maryland, Baltimore and University of Maryland, College Park.
University of Maryland, Baltimore (UMB) and University of Maryland, College Park have granted US-based biotech startup Cellth Systems exclusive licensing rights for the commercial development of a cancer treatment technology.
Molecular diagnostics firm Cellth has developed cell-tethering technology used for real-time analysis of circulating tumour cells (CTCs).
When CTCs appear in the blood of people with cancer it can be an early indication of the pace the disease may spread and is often linked to survival rate.
Previously there was…
